Opportunity Information: Apply for PAR 18 114

The National Institutes of Health, through the National Center for Complementary and Integrative Health (NCCIH), offered this discretionary grant opportunity titled "Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33 Clinical Trial Required)" (Funding Opportunity Number PAR-18-114; CFDA 93.213). The central purpose of the program is to support research that explains how complementary or integrative mind and body interventions produce their clinical effects, with the practical goal of using that mechanistic understanding to refine, optimize, and better target these interventions for specific health conditions and disorders. In other words, the opportunity is aimed less at simply testing whether an intervention works and more at uncovering the biological, psychological, behavioral, and/or physiological pathways that drive outcomes, so that interventions can be improved and deployed more effectively.

The award mechanism is a phased R61/R33 design, which typically supports a staged research plan that begins with an initial, milestone-driven phase (R61) and can transition to a second phase (R33) if predefined goals are met. This structure is meant to encourage innovative but rigorous mechanistic work, where early feasibility or proof-of-mechanism steps are tightly linked to a later, more definitive phase. A key feature of this specific announcement is that a clinical trial is required, meaning applicants are expected to incorporate a clinical trial component as part of the mechanistic research strategy rather than proposing only preclinical, observational, or theory-only work. The underlying emphasis is on mechanistic studies within NCCIH high-priority research topics, reflecting NCCIHs interest in advancing interventions like mindfulness-based approaches, meditation, yoga, tai chi, acupuncture, biofeedback, breathing practices, and other mind-body strategies when they are studied in ways that can clarify causal pathways and inform optimization.

Eligibility is broad and includes a wide range of domestic organizations: state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits both with and without 501(c)(3) status (so long as they are not institutions of higher education when applying under those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other applicant types. The announcement also explicitly highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. This emphasis signals an intent to encourage participation from diverse institutions and community-linked entities that may be well positioned to study mind-body interventions in real-world populations.

The opportunity places clear limits on foreign involvement. Non-domestic (non-U.S.) entities and non-domestic (non-U.S.) institutions are not eligible to apply as the primary applicant organization. However, non-domestic components of U.S. organizations are eligible, and foreign components (as defined by the NIH Grants Policy Statement) are allowed. Practically, that means the applicant organization must be U.S.-based, but the project can include certain international elements or collaborations when justified and structured in line with NIH policy.

Administratively, the funding instrument is a grant within the health activity category. The source data lists an original closing date of 2019-06-28 and a creation date of 2017-11-02. Award ceiling and expected number of awards are not specified in the provided summary. Overall, the opportunity is best understood as a mechanism-focused, milestone-based clinical trial funding pathway designed to push the field beyond efficacy questions and toward actionable understanding of how mind-body interventions work, for whom they work, and how they can be systematically improved.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33 Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213.
  • This funding opportunity was created on 2017-11-02.
  • Applicants must submit their applications by 2019-06-28. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 114

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the name of this NIH/NCCIH grant opportunity?

The opportunity is titled: "Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33 Clinical Trial Required)".

What is the Funding Opportunity Number (FON) for this announcement?

The Funding Opportunity Number is PAR-18-114.

Which NIH center is offering this grant?

This opportunity is offered by the National Institutes of Health (NIH) through the National Center for Complementary and Integrative Health (NCCIH).

What is the CFDA number associated with this funding opportunity?

The CFDA number listed is 93.213.

What is the main purpose of this funding opportunity?

The central purpose is to support research that explains how complementary or integrative mind and body interventions produce their clinical effects, with the practical goal of using that mechanistic understanding to refine, optimize, and better target these interventions for specific health conditions and disorders.

Is this grant primarily about testing whether an intervention works?

No. The emphasis is less on simply testing whether an intervention works and more on uncovering the biological, psychological, behavioral, and/or physiological pathways that drive outcomes, so that interventions can be improved and used more effectively.

What does "mechanistic studies" mean in the context of this opportunity?

In this context, mechanistic studies are research efforts aimed at identifying and clarifying the causal pathways through which mind and body interventions lead to clinical outcomes. The intent is to generate actionable knowledge that supports intervention optimization (for example, refining delivery, dosing, targeting to populations/conditions, or selecting outcomes linked to specific mechanisms).

What types of interventions are considered "mind and body interventions" here?

The summary indicates NCCIH interest in interventions such as mindfulness-based approaches, meditation, yoga, tai chi, acupuncture, biofeedback, breathing practices, and other mind-body strategies, particularly when studied in ways that clarify mechanisms and inform optimization.

What is the award mechanism used for this opportunity?

The award uses a phased R61/R33 design.

What does the R61/R33 phased design mean?

It typically supports a staged plan that begins with an initial, milestone-driven phase (R61) and can transition to a second phase (R33) if predefined goals are met. The structure is intended to encourage innovative but rigorous mechanistic work by tightly linking early proof-of-mechanism or feasibility steps to a later, more definitive phase.

Does this funding opportunity require milestones?

Yes. The R61 phase is described as milestone-driven, and transition to the R33 phase depends on whether predefined goals are met.

Is a clinical trial required under this announcement?

Yes. This is explicitly a "Clinical Trial Required" opportunity, meaning applicants are expected to include a clinical trial component as part of the mechanistic research strategy.

Can an application be purely preclinical, observational, or theory-only?

Based on the summary provided, the expectation is that applicants incorporate a clinical trial component rather than proposing only preclinical, observational, or theory-only work.

What kinds of research topics are prioritized?

The emphasis is on mechanistic studies within NCCIH high-priority research topics, focused on advancing understanding of how mind and body interventions work and how they can be optimized.

Who is eligible to apply?

Eligibility is broad and includes many types of domestic (U.S.) organizations, including:

  • State, county, city, or township governments
  • Special district governments
  • Independent school districts
  • Public and state-controlled institutions of higher education
  • Private institutions of higher education
  • Federally recognized Native American tribal governments
  • Tribal organizations that are not federally recognized
  • Public housing authorities and Indian housing authorities
  • Nonprofits with or without 501(c)(3) status (as noted in the summary)
  • For-profit organizations (other than small businesses)
  • Small businesses
  • Other applicant types

Are community-based or faith-based organizations eligible?

Yes. The announcement explicitly highlights faith-based or community-based organizations among additional eligible applicants.

Are minority-serving institutions specifically encouraged or identified as eligible?

Yes. The summary explicitly highlights eligibility for institutions such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).

Are U.S. territories or possessions included as eligible applicants?

Yes. The summary explicitly includes U.S. territories or possessions among the highlighted eligible applicants.

Can federal agencies apply?

Yes. The summary lists eligible federal agencies among the additional eligible applicants.

Are non-U.S. (foreign) organizations eligible to apply as the primary applicant?

No. Non-domestic (non-U.S.) entities and non-domestic institutions are not eligible to apply as the primary applicant organization.

Is any foreign involvement allowed in projects funded by this opportunity?

Yes. While the primary applicant must be U.S.-based, the summary states that non-domestic components of U.S. organizations are eligible and that foreign components are allowed (as defined by the NIH Grants Policy Statement). This indicates international elements or collaborations may be included when appropriately justified and structured under NIH policy.

What is the funding instrument and activity category?

The funding instrument is a grant, and the activity category is health.

What are the key dates provided for this opportunity?

The source data lists a creation date of 2017-11-02 and an original closing date of 2019-06-28.

Is the award ceiling specified?

No. The provided summary indicates the award ceiling is not specified.

Is the expected number of awards specified?

No. The provided summary indicates the expected number of awards is not specified.

How should applicants think about "optimization" in this program?

Based on the summary, optimization refers to using mechanistic insights to refine and improve interventions, including better targeting to specific health conditions and disorders and improving how interventions are deployed, rather than only evaluating efficacy in a general sense.

What makes this opportunity distinct from typical clinical trial funding?

What stands out in the provided description is the combination of: (1) a required clinical trial, (2) a strong emphasis on mechanistic explanations of clinical effects, and (3) a phased, milestone-based R61/R33 structure intended to move from early mechanistic feasibility/proof steps to a more definitive stage if milestones are achieved.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Community Partnerships to Advance Research (CPAR) (R01 Clinical Trial Optional)

Previous opportunity: Agency for Healthcare Research and Quality (AHRQ)-sponsored National Research Service Award (NRSA)Individual Postdoctoral Fellowship (F32)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 114

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 114) also looked into and applied for these:

Funding Opportunity
Improving Outcomes for Disorders of Human Communication (R01 Clinical Trial Optional) Apply for PA 18 287

Funding Number: PA 18 287
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Minority HIV/AIDS Research Initiative (MARI) to Build HIV Prevention, Treatment and Research Capacity in Disproportionately Affected Black and Hispanic Communities and Among Historically Underrepresented Researchers Apply for RFA PS 16 00103CONT18

Funding Number: RFA PS 16 00103CONT18
Agency: Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: Case Dependent
Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33 Clinical Trial Required) Apply for PAR 18 115

Funding Number: PAR 18 115
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Emerging Infectious Sentinel Networks (EISN) Research Apply for RFA CK 16 00103CONT18

Funding Number: RFA CK 16 00103CONT18
Agency: Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: Case Dependent
NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 18 118

Funding Number: PAR 18 118
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional) Apply for PA 18 288

Funding Number: PA 18 288
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Population-based HIV Impact Assessments in Resource-Constrained Settings under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 1409A

Funding Number: CDC RFA GH14 1409A
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R03 Clinical Trial Required) Apply for PA 18 198

Funding Number: PA 18 198
Agency: National Institutes of Health
Category: Health
Funding Amount: $50,000
Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R21 Clinical Trial Required) Apply for PA 18 197

Funding Number: PA 18 197
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Systems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) Apply for RFA AG 18 021

Funding Number: RFA AG 18 021
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03 Clinical Trial Optional) Apply for PA 18 200

Funding Number: PA 18 200
Agency: National Institutes of Health
Category: Health
Funding Amount: $50,000
Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R03 Clinical Trial Optional) Apply for PA 18 201

Funding Number: PA 18 201
Agency: National Institutes of Health
Category: Health
Funding Amount: $50,000
Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R21 Clinical Trial Optional) Apply for PA 18 202

Funding Number: PA 18 202
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R01 Clinical Trial Required) Apply for PA 18 192

Funding Number: PA 18 192
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01 Clinical Trial Optional) Apply for PA 18 193

Funding Number: PA 18 193
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R01 Clinical Trial Optional) Apply for PA 18 194

Funding Number: PA 18 194
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21 Clinical Trial Optional) Apply for PA 18 199

Funding Number: PA 18 199
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Mechanisms of Disparities for HIV- Related Co-morbidities in Health Disparity Populations (R01-Clinical Trial Not Allowed) Apply for RFA MD 18 002

Funding Number: RFA MD 18 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $450,000
NIMH Exploratory/Developmental Research Grant (R21 - Clinical Trial Not Allowed) Apply for PA 18 350

Funding Number: PA 18 350
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Selected Topics in Transfusion Medicine (R01 Clinical Trial Optional) Apply for PAR 18 126

Funding Number: PAR 18 126
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 114", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: